FR12C0005I2 - Use of an estrogen-progestogen composition as an oral contraceptive - Google Patents

Use of an estrogen-progestogen composition as an oral contraceptive

Info

Publication number
FR12C0005I2
FR12C0005I2 FR12C0005C FR12C0005C FR12C0005I2 FR 12C0005 I2 FR12C0005 I2 FR 12C0005I2 FR 12C0005 C FR12C0005 C FR 12C0005C FR 12C0005 C FR12C0005 C FR 12C0005C FR 12C0005 I2 FR12C0005 I2 FR 12C0005I2
Authority
FR
France
Prior art keywords
estrogen
oral contraceptive
progestogen composition
progestogen
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR12C0005C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR12C0005(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Publication of FR12C0005I1 publication Critical patent/FR12C0005I1/en
Application granted granted Critical
Publication of FR12C0005I2 publication Critical patent/FR12C0005I2/en
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/811Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
FR12C0005C 1996-10-08 2012-01-19 Use of an estrogen-progestogen composition as an oral contraceptive Active FR12C0005I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (en) 1996-10-08 1996-10-08 NOVEL HORMONONAL COMPOSITION AND ITS USE
EP97944940A EP0956022B1 (en) 1996-10-08 1997-10-08 Hormonal composition consisting of an oestrogen compound and of a progestational compound

Publications (2)

Publication Number Publication Date
FR12C0005I1 FR12C0005I1 (en) 2012-02-24
FR12C0005I2 true FR12C0005I2 (en) 2016-06-24

Family

ID=9496456

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9612239A Expired - Fee Related FR2754179B1 (en) 1996-10-08 1996-10-08 NOVEL HORMONONAL COMPOSITION AND ITS USE
FR12C0005C Active FR12C0005I2 (en) 1996-10-08 2012-01-19 Use of an estrogen-progestogen composition as an oral contraceptive

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9612239A Expired - Fee Related FR2754179B1 (en) 1996-10-08 1996-10-08 NOVEL HORMONONAL COMPOSITION AND ITS USE

Country Status (38)

Country Link
US (4) US6831073B1 (en)
EP (2) EP0956022B1 (en)
JP (1) JP4883542B2 (en)
KR (2) KR20000048981A (en)
CN (3) CN1239893A (en)
AP (1) AP1171A (en)
AR (2) AR009113A1 (en)
AT (2) ATE353652T1 (en)
AU (1) AU745571B2 (en)
BR (1) BR9712274A (en)
CA (1) CA2268358C (en)
CL (1) CL2011000017A1 (en)
CZ (1) CZ298402B6 (en)
DE (3) DE69737373T2 (en)
DK (2) DK1334725T3 (en)
DZ (1) DZ2327A1 (en)
ES (2) ES2282539T3 (en)
FR (2) FR2754179B1 (en)
HK (1) HK1210708A1 (en)
HU (2) HU227450B1 (en)
ID (1) ID21569A (en)
IL (1) IL129194A (en)
LU (1) LU91932I2 (en)
MA (1) MA24370A1 (en)
MY (1) MY128482A (en)
NO (3) NO324357B1 (en)
NZ (1) NZ334876A (en)
OA (1) OA11033A (en)
PL (1) PL192979B1 (en)
PT (2) PT1334725E (en)
RU (1) RU2274450C2 (en)
SK (2) SK285056B6 (en)
TN (1) TNSN97164A1 (en)
TR (1) TR199900764T2 (en)
TW (1) TW491704B (en)
WO (1) WO1998015279A1 (en)
YU (1) YU18099A (en)
ZA (1) ZA979011B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (en) 1993-12-22 1996-02-01 Schering Ag Composition for contraception
DE19549264A1 (en) * 1995-12-23 1997-06-26 Schering Ag Contraception procedure and kit
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030355A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
WO2001030356A1 (en) * 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
FR2814074B1 (en) * 2000-09-15 2003-03-07 Theramex NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
FR2823976A1 (en) * 2001-04-25 2002-10-31 Theramex NOVEL HORMONAL COMPOSITION AND ITS USE
UY29185A1 (en) * 2004-11-02 2006-05-31 Schering Ag SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE
PE20081895A1 (en) 2007-03-26 2009-01-26 Theramex ORAL CONTRACEPTIVE REGIME
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
KR20240005348A (en) 2022-07-05 2024-01-12 신규식 System For Trading and Managing Patent

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (en) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk Production of high-purity 4-4'-dihydroxydiphenyl-sulfone
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
DK174724B1 (en) 1986-07-15 2003-10-06 Wyeth Corp Use of a composition comprising an estrogen and a progestogen for the preparation of a dosage form to provide hormone replacement therapy and contraception for women during the premenopause and pack to provide the composition
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
EP0559240B1 (en) * 1987-09-24 2001-12-05 Jencap Research Limited Contraceptive packages containing oestrogen and progestin
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (en) * 1992-09-21 1995-01-06 Theramex New pharmaceutical compositions based on nomegestrol derivatives and methods for obtaining them.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (en) * 1993-12-22 1996-02-01 Schering Ag Composition for contraception
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (en) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivatives of sex hormones
FR2737411B1 (en) 1995-08-01 1997-10-17 Theramex NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19540253C2 (en) 1995-10-28 1998-06-04 Jenapharm Gmbh Multi-phase preparation for contraception based on natural estrogens
DE19549264A1 (en) 1995-12-23 1997-06-26 Schering Ag Contraception procedure and kit
AU2926897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041869A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041871A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041872A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
AU3961697A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
AU3888597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
DE69724796T2 (en) 1996-07-26 2004-07-01 Wyeth BIPHASIC ORAL PREVENTION METHOD AND KIT CONTAINING A COMBINATION OF PROGESTINE AND AN ESTROGEN
NZ333862A (en) 1996-07-26 2000-08-25 American Home Prod Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
WO2001030355A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
FR2754179B1 (en) * 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
DE19705229C2 (en) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP1007052B1 (en) 1997-08-27 2004-10-13 Ortho-McNeil Pharmaceutical, Inc. Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (en) 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
CN1270521A (en) 1997-09-12 2000-10-18 美国家用产品公司 Oral contraceptive preparation having a first phase comprising comprising progestin/estrogen and a second phase comprising progestin
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof

Also Published As

Publication number Publication date
CA2268358C (en) 2010-04-20
NO324357B1 (en) 2007-10-01
NO2017043I1 (en) 2017-08-08
SK285056B6 (en) 2006-05-04
NO2017043I2 (en) 2019-01-25
EP0956022A1 (en) 1999-11-17
EP0956022B1 (en) 2003-04-23
PL332610A1 (en) 1999-09-27
CN1239893A (en) 1999-12-29
TNSN97164A1 (en) 1999-12-31
CN101229173A (en) 2008-07-30
US7749987B2 (en) 2010-07-06
OA11033A (en) 2003-03-06
ID21569A (en) 1999-06-24
HUP9904508A2 (en) 2000-06-28
AU4627397A (en) 1998-05-05
IL129194A0 (en) 2000-02-17
HUP9904508A3 (en) 2001-01-29
ES2198006T3 (en) 2004-01-16
TR199900764T2 (en) 1999-07-21
DK1334725T3 (en) 2007-06-11
KR20060084864A (en) 2006-07-25
NO991593L (en) 1999-06-07
DK0956022T3 (en) 2003-08-04
RU2274450C2 (en) 2006-04-20
JP4883542B2 (en) 2012-02-22
DE69737373D1 (en) 2007-03-29
PL192979B1 (en) 2006-12-29
HK1210708A1 (en) 2016-05-06
DE69721314D1 (en) 2003-05-28
TW491704B (en) 2002-06-21
KR20000048981A (en) 2000-07-25
FR2754179A1 (en) 1998-04-10
ATE353652T1 (en) 2007-03-15
EP1334725B1 (en) 2007-02-14
HUS1200002I1 (en) 2016-08-29
FR12C0005I1 (en) 2012-02-24
NZ334876A (en) 2001-06-29
CZ298402B6 (en) 2007-09-19
PT1334725E (en) 2007-05-31
LU91932I9 (en) 2018-12-27
PT956022E (en) 2003-07-31
ZA979011B (en) 1998-06-03
CL2011000017A1 (en) 2011-06-24
CA2268358A1 (en) 1998-04-16
DE69737373T2 (en) 2007-06-21
AP1171A (en) 2003-06-30
KR100782638B1 (en) 2007-12-06
AR009113A1 (en) 2000-03-08
US6831073B1 (en) 2004-12-14
NO2012002I1 (en) 2012-01-24
YU18099A (en) 2002-03-18
US20040220163A1 (en) 2004-11-04
JP2002509524A (en) 2002-03-26
DE69721314T2 (en) 2004-02-12
EP1334725A2 (en) 2003-08-13
IL129194A (en) 2003-06-24
WO1998015279A1 (en) 1998-04-16
NO2012002I2 (en) 2013-04-02
NO991593D0 (en) 1999-03-31
HU227450B1 (en) 2011-06-28
SK43899A3 (en) 1999-12-10
DZ2327A1 (en) 2002-12-28
FR2754179B1 (en) 1998-12-24
MA24370A1 (en) 1998-07-01
US6906049B1 (en) 2005-06-14
AU745571B2 (en) 2002-03-21
AP9901500A0 (en) 1999-06-30
DE122012000010I1 (en) 2012-04-19
ATE238057T1 (en) 2003-05-15
BR9712274A (en) 1999-08-31
AR073972A2 (en) 2010-12-15
CZ9901120A3 (en) 2000-11-15
SK285455B6 (en) 2007-01-04
MY128482A (en) 2007-02-28
CN104706641A (en) 2015-06-17
LU91932I2 (en) 2012-03-13
ES2282539T3 (en) 2007-10-16
EP1334725A3 (en) 2004-01-21
US20070281912A1 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
FR12C0005I2 (en) Use of an estrogen-progestogen composition as an oral contraceptive
DE19681287T1 (en) Oral formulation of 2-methylthienobenzodiazepine
FI963421A0 (en) Oral auxiliary compositions
BR9509200A (en) Composition of matter
ATE304359T1 (en) ANTESTROGEN AND PROGESTIN CONTAINING ORAL CONTRACEPTIVES
FR2726906B1 (en) INSTRUMENT OF INDICATION
BR9612555A (en) Detergent compositions containing fragrance precursors and the fragrance precursors of these compositions
PT1014987E (en) ORAL COMPOSITIONS OF LEVOSIMENDANO
PT906101E (en) FORMULATIONS OF PROLONGED LIBERATION CONTAINING MIZOLASTIN
ID16838A (en) COMPOSITION OF DEKAFLUOROPENTANA
DE59709372D1 (en) Fragrance compositions containing substituted 2-acetylbenzofurans
DE69528771D1 (en) IMIDAZOLINE COMPOSITIONS CONTAINING SILICON
ID17419A (en) COMPOSITION OF DEKAFLUOROPENTANA
FR2710673B1 (en) Composition of facing plaster.
FR2756310B1 (en) AUXILIARY AMOUNT OF SCAFFOLDING
ID24232A (en) COMPOSITION OF NON-COROSIVE COOLING MATERIALS
MD249F1 (en) Composition of ingredients for "night" liqueur
UA25103A (en) COMPOSITION OF INGREDIENTS FOR SPECIAL Vodka "ZOLOTE RUSLO"
UA25104A (en) COMPOSITION OF INGREDIENTS FOR SPECIAL "VESILHA" Vodka
UA25802A (en) COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM
UA25801A (en) COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM
UA25803A (en) COMPOSITION OF INGREDIENTS OF OLD DOCTOR BALM
UA1693S (en) SET OF LABELS "AMOUNTS"
UA2094S (en) LABEL OF THE MEDICINAL PREPARATION "ASPARKAM"
UA1957S (en) LABEL OF THE MEDICINAL PREPARATION "ASPARKAM"